Lifsa Drugs LLC
3 drugs in NADAC|3 Generic,0 Brand
Lifsa Drugs LLC lists 3 NDCs in the CMS NADAC file (3 generic, 0 brand), at an average NADAC of $9.88 per unit. The firm's full portfolio, pricing trend are listed below.
Total Drugs
3
3G / 0B
Avg Price / Unit
$9.8841
$2.52 – $14.61
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
of 3 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Metformin Hydrochloride market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Biguanide therapeutic class
Review the broader class where Lifsa Drugs LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Lifsa Drugs LLC make?
Lifsa Drugs LLC lists 3 NDCs in the CMS NADAC file — 3 generic and 0 brand products.
What is the average price of Lifsa Drugs LLC drugs?
The average NADAC across Lifsa Drugs LLC's portfolio is $9.8841 per unit, ranging from $2.5208 to $14.6050.
What types of drugs does Lifsa Drugs LLC make?
Lifsa Drugs LLC makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Biguanide (2), Muscle Relaxant (1).
Has Lifsa Drugs LLC had any drug recalls?
No FDA enforcement recalls are matched to Lifsa Drugs LLC in the openFDA feed.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
METFORMIN HCL 750 MG TABLET Metformin Hydrochloride | $14.6050 per EA | — |
METFORMIN HCL 625 MG TABLET Metformin Hydrochloride | $12.5266 per EA | — |
CHLORZOXAZONE 250 MG TABLET Chlorzoxazone | $2.5208 per EA | — |